CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 74 filers reported holding CATALYST BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $61,000 | -26.5% | 67,605 | +380.9% | 0.00% | -100.0% |
| Q2 2020 | $83,000 | -90.3% | 14,057 | -88.8% | 0.00% | -83.3% |
| Q4 2019 | $855,000 | -55.3% | 125,575 | -46.8% | 0.01% | -33.3% |
| Q1 2019 | $1,914,000 | -48.2% | 235,930 | -49.6% | 0.01% | -76.3% |
| Q4 2018 | $3,693,000 | -68.8% | 467,997 | -57.3% | 0.04% | -24.0% |
| Q3 2018 | $11,828,000 | +84.2% | 1,097,180 | +99.4% | 0.05% | -47.9% |
| Q2 2018 | $6,423,000 | – | 550,352 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |